NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,559 | +4.1% | 60 | -4.8% | 0.00% | – |
| Q2 2022 | $4,379 | -37.1% | 63 | -25.0% | 0.00% | – |
| Q1 2022 | $6,959 | +15.9% | 84 | +5.0% | 0.00% | – |
| Q4 2021 | $6,006 | -72.8% | 80 | -57.9% | 0.00% | -100.0% |
| Q3 2021 | $22,072 | -45.6% | 190 | +3.8% | 0.00% | -50.0% |
| Q2 2021 | $40,593 | +207.1% | 183 | +83.0% | 0.00% | +100.0% |
| Q1 2021 | $13,218 | -23.6% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $17,304 | +210.9% | 100 | +100.0% | 0.00% | – |
| Q3 2020 | $5,566 | -92.2% | 50 | -95.9% | 0.00% | -100.0% |
| Q2 2020 | $71,634 | +431.9% | 1,208 | +504.0% | 0.01% | +400.0% |
| Q1 2020 | $13,468 | +59.8% | 200 | +100.0% | 0.00% | 0.0% |
| Q4 2019 | $8,427 | -82.1% | 100 | -84.1% | 0.00% | -75.0% |
| Q3 2019 | $47,111 | – | 630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |